F

Fennec Pharmaceuticals
D

FENC

11.350
USD
-0.30
(-2.58%)
مغلق
حجم التداول
7,355
الربح لكل سهم
0
العائد الربحي
-
P/E
-95
حجم السوق
398,012,255
أصول ذات صلة
المزيد
المقالات
المزيد

العنوان: Fennec Pharmaceuticals

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.